Welcome to the GHAPP Digital Hub

The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).

The GHAPP Digital Hub is the place for all GI & Liver digital education for APPs. Here you will have access to podcasts and various short video modules.

bannershape

bgdots

bannershape

sectionimg

Faculty

Alison Moe

PA-C

Atlanta, GA, USA

Ann Moore

NP

Phoenix, AZ

Christina Hanson

FNP-C

South Denver Gastroenterology

Gabriella McCarty

NP-C

North Shore Gastroenterology

Tedra Gray

NP-C

Sinai Medical Group

Kimberly Orleck

PA-C

Atlanta Gastroenterology Associates

Kimberly Kearns

NP-C

DuPage Medical Group

Anne Feldman

NP

Cleveland Clinic Cleveland, OH

Corrie Berk

NP

The Texas Liver Institute

Lisa Richards

NP

UC San Diego

Jonathan Yeh

PA

Columbia University Irving Medical Center

Whitney Steinmetz

NP

Presbyterian Healthcare Services

Patrick Horne

NP

University of Florida

April Morris

FNP

Liver Institute of Virginia

Robin Soto

NP

UC San Diego Health

Allysa Sagese

NP

New York, New York

Renee Pozza

NP

San Diego, CA

Jordan Mayberry

PA-C

UT Southwestern Medical Center

Jeremy Davis

ACNP

Shreveport, LA

Allison Moser

FNP-BC

Chicago, IL

Podcasts

The Clinical Utility of Guselkumab in CD

Simplifying Access: Prior Authorization Part 1

Simplifying Access: Prior Authorization Part 2

Simplifying Access: Evolving Drug Distribution Channels

GHAPPcast: The Clinical Utility of Guselkumab in UC

GHAPPcast Part 3: Provider & Patient Support

GHAPPcast Part 2: Diagnosis and Management

GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis

GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis

Building a Sense of Urgency for PBC Patient Evaluation/Monitoring

Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy

Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy

Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression

Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically

Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively

Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA

GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey

GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024

Webcasts

Navigating New Horizons: Evolutions of MASH Care

Post Conference MASH Highlights from AASLD

Post Conference MASH Highlights From ACG

Post Conference MASH Highlights From EASL

Post Conference MASH Highlights From DDW

Hot Topics in Chronic Liver Disease and Gi Disorders

Defining, Diagnosing, & Treating MASH

Lifestyle Modifications for Patients With MASH

Treatment of Metabolic Disorders and the Role of APPs in MASH

Updates On Approved Treatments for MASH

MASH Bootcamp Q&A

Identifying & Diagnosing MASH Patients with Non-Invasive Tests

2024 IBD Bootcamp

PBC New Therapeutic

FAQ Video Modules

What Are the Most Critical Updates in Cirrhosis Research That Clinicians Should Be Aware Of?

How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?

How Does the Guselkumab Data Align With the STRIDE II Guidelines?

KOL Interview: Can You Discuss Any Recent Breakthroughs in the Management of Cirrhosis?

What Should Patients Know About Living With Cirrhosis?

What Are Predictive Risk Factors for Disease Severity in CD and UC?

What Lifestyle Changes Are Essential for Managing Cirrhosis Effectively?

How Can You Support a Shared Decision Making Process With the Patient?

How Can Physicians Better Care for Patients With Cirrhosis?

Is There a Correlation Between Myeloid Cells Expressing CD64 and Endoscopic Disease Severity?

Why Is Binding CD64+ Important When Discussing IL-23 Directed Therapy?

Provide Immunologic Rationale for IL-23 Directed Therapy in IBD

What Is the Role of the IL-23/IL-17 Axis in IBD?

Describe the IL-23/IL-17 Axis

Define, Compare, and Contrast Humoral and Cell-Mediated Immunity

How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?

What Are the Consequences of MASH Going Untreated?

What is MASH?

What Does It Mean for a Biosimilar to Be Interchangeable, and Why Is That Important?

What Resources Do You Use to Understand the Latest Approaches to Managing IBS-C Patients?

Journal Club Video Modules

Week 48 Efficacy of Guselkumab vs. Ustekinumab in Crohn’s Disease: Insights from GALAXI 2 & 3

Efficacy & Safety of Subcutaneous Guselkumab: 48-Week Results from the Phase 3 GRAVITI Study

Efficacy and Safety of Guselkumab in Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results

Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results

Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Medication Review Video Modules

What Are Guselkumab's Other FDA Indications and How Might That Affect Patient Care?

What Is the Efficacy of Guselkumab in Ulcerative Colitis and Crohn's Disease?

What Is the Safety Profile of Guselkumab in Ulcerative Colitis and Crohn's Disease?

How Is Guselkumab Dosed in IBD?

What Is Non-Responder Imputation and How Is It Utilized in Clinical Trials?

Describe the Mechanism of Action of Guselkumab

What Is Resmetirom and How Does It Work to Treat MASH?

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?

Publications

Comment on "Abbreviated anorectal biofeedback therapy is beneficial in symptomatic improvement of functional defecatory disorder"

Precut fistulotomy made easy!

Oral microbes and gastrointestinal cancers: new strategies and insights

Advancing Upper Gastrointestinal Cancer Detection: A Single-Center Pilot Study Exploring the Potential of Electrical Impedance Spectroscopy in Endoscopic Procedures

Post-endoscopy esophageal squamous cell carcinoma with invasion of the muscularis mucosa or deeper detected in surveillance endoscopy after esophageal endoscopic resection

Sodium-glucose cotransporter 2 inhibitors and bullous pemphigoid risk in US and global population: real world evidences

Multicystic biliary hamartoma with long-term gradual enlargement treated by laparoscopic partial hepatectomy

Mindin orchestrates the macrophage-mediated resolution of liver fibrosis in mice

Challenges in the clinical management of rare diseases and center-based multidisciplinary approach to creating solutions

Incidental Gallbladder Cancer: A Comprehensive Review

A Video Decision Aid Decreases Fear of Colonoscopy After an Abnormal Fecal Immunochemical Test Result: A Pilot Study

Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems

Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes

The association between colonic diverticulosis and colorectal polyps in a retrospective cohort study

Predictive Ability of Previous Pain and Disease Conditions on the Presentation of Post-COVID Pain in a Danish Cohort of Adult COVID-19 Survivors

Differential Association of Hepatocellular Carcinoma Related to Hepatitis B Between Urban and Rural Areas in Africa Using Satellite Spatial Scaling Data

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)

Brain sensing of metabolic state regulates circulating monocytes

Early detection of esophageal cancer: Evaluating AI algorithms with multi-institutional narrowband and white-light imaging data

Probiotic Membrane-Modified Nanocomposite Alleviates Inflammation and Microbiota Dysbiosis in Colitis by Scavenging Oxidative Stress and Restoring Immune Homeostasis

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play